OpenURL Connection Search

Select item for more details and to access through your institution.

Correspondence.
Published in:
2002
By:
- Miall, F.;
- Rye, A.;
- Fraser, M.;
- Hunter, A.;
- Snowden, J. A.;
- Corti, P.;
- Urdezo, C.;
- Tagliabue, A.;
- Volpe, A. Della;
- Annaloro, C.;
- Tagliaferri, E.;
- Balduzzi, A.;
- Hequet, O.;
- Dumontet, C.;
- Jaafario Corbin, A El;
- Salles, G.;
- Espinouse, D.;
- Arnaud, P.;
- Thieblemont, C.
Publication type:
Letter
Patient‐ versus clinician‐reported symptoms in the POLARIX study.
Published in:
Hematological Oncology, 2023, v. 41, p. 414, doi. 10.1002/hon.3164_305
By:
- Thompson, C. A.;
- Mehta‐Shah, N.;
- Flowers, C.;
- Salles, G.;
- Tilly, H.;
- Chua, N.;
- Casasnovas, R.;
- Miall, F.;
- Kim, T. M.;
- Tsai, C.;
- Nasta, S.;
- Lee, S. T.;
- Craine, V.;
- Campinha‐Bacote, A.;
- Hirata, J.;
- Lee, C.;
- Sugidono, M.;
- Friedberg, J. W.
Publication type:
Article
AVELUMAB MONOTHERAPY FOLLOWED BY A PET ADAPTED CHEMOTHERAPY APPROACH IN THE FIRST LINE TREATMENT OF CLASSICAL HODGKIN LYMPHOMA: INITIAL RESULTS FROM THE AVENUE WINDOW STUDY.
Published in:
Hematological Oncology, 2023, v. 41, p. 162, doi. 10.1002/hon.3163_108
By:
- Collins, G. P.;
- Hawkes, E. A.;
- Kirkwood, A. A.;
- Clifton‐Hadley, L.;
- Tyson, C.;
- Barsoum, E.;
- Pettengell, R.;
- Medd, P. G.;
- McKay, P.;
- Miall, F.;
- Radford, J.;
- Iyengar, S.;
- Sud, A.;
- Phillips, N.;
- Burton, C.;
- Peggs, K.;
- Ardavan, A.;
- Grigg, A. P.;
- Lee, S.;
- Scott, A.
Publication type:
Article
POLATUZUMAB VEDOTIN + RITUXIMAB + LENALIDOMIDE IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL): PRIMARY ANALYSIS OF A PHASE 1B/2 TRIAL.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.155_2880
By:
- Diefenbach, C;
- Abrisqueta, P;
- Gonzalez-Barca, E;
- Panizo, C;
- Arguinano Perez, J. Maria;
- Miall, F;
- Bastos-Oreiro, M;
- Lopez-Guillermo, A;
- Banerjee, L;
- McMillan, A;
- Hirata, J;
- Musick, L;
- Saha, S;
- Croft, B;
- Seymour, E
Publication type:
Article
9P GAIN PREDICTS OUTCOMES IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL) TREATED WITH R‐GEMOX +/‐ ATEZOLIZUMAB. ARGO: A RANDOMISED PHASE II STUDY.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.11_2880
By:
- Davies, A;
- McKay, P;
- Osborne, W;
- Stanton, L;
- Tansley‐Hancock, O;
- Lawrence, M;
- Mercer, K;
- Allen, A;
- Pottinger, B;
- Zhelyazkova, A;
- Miall, F;
- Rafferty, J;
- Sale, B;
- Cucco, F;
- Nunn, L;
- Coleman, A;
- Griffiths, G;
- Du, M. Q;
- Burton, C;
- Barrons, S
Publication type:
Article
REAL WORLD OUTCOMES AND RESPONSES TO SECOND‐LINE THERAPY IN RELAPSED/REFRACTORY HODGKIN LYMPHOMA: A MULTICENTRE UK STUDY.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.106_2880
By:
- Shotton, R.;
- Kirkwood, A. A.;
- Northend, M.;
- Fathoal, D.;
- Burton, K.;
- Ferguson, G.;
- Aiken, L.;
- Shrubsole, C.;
- Henry, L.;
- Owen, M.;
- Oliver, R.;
- Martinez‐Calle, N.;
- Etherington, A.;
- Gallop‐Evans, E.;
- Burton, C.;
- Miall, F.;
- Osborne, W.;
- Le Dieu, R.;
- McKay, P.;
- Ardeshna, K.
Publication type:
Article
POLATUZUMAB VEDOTIN (POLA) + OBINUTUZUMAB (G) + LENALIDOMIDE (LEN) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL): PHASE IB/II INTERIM ANALYSIS.
Published in:
Hematological Oncology, 2019, v. 37, p. 175, doi. 10.1002/hon.132_2629
By:
- Diefenbach, C.;
- Kahl, B.;
- Banerjee, L.;
- McMillan, A.;
- Ramchandren, R.;
- Miall, F.;
- Briones, J.;
- Cordoba, R.;
- Gonzalez‐Barca, E.;
- Panizo, C.;
- Hirata, J.;
- Chang, N.;
- Musick, L.;
- Abrisqueta, P.
Publication type:
Article
POLATUZUMAB VEDOTIN (POLA) + OBINUTUZUMAB (G) + LENALIDOMIDE (LEN) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL): PHASE IB/II INTERIM ANALYSIS.
Published in:
Hematological Oncology, 2019, v. 37, p. 175, doi. 10.1002/hon.132_2629
By:
- Diefenbach, C.;
- Kahl, B.;
- Banerjee, L.;
- McMillan, A.;
- Ramchandren, R.;
- Miall, F.;
- Briones, J.;
- Cordoba, R.;
- Gonzalez‐Barca, E.;
- Panizo, C.;
- Hirata, J.;
- Chang, N.;
- Musick, L.;
- Abrisqueta, P.
Publication type:
Article
RESULTS OF a MULTICENTRE UK-WIDE STUDY EVALUATING THE EFFICACY OF BRENTUXIMAB VEDOTIN IN RELAPSED, REFRACTORY CLASSICAL HODGKIN LYMPHOMA IN THE PRE-TRANSPLANT NAÏVE SETTING.
Published in:
Hematological Oncology, 2017, v. 35, p. 82, doi. 10.1002/hon.2437_70
By:
- Eyre, T.A.;
- Phillips, E.H.;
- Linton, K.M.;
- Kassam, S.;
- Gibb, A.;
- Allibone, S.;
- Peggs, K.;
- Burton, C.;
- Stewart, G.;
- Ledieu, R.;
- Booth, C.;
- Osborne, W.;
- Miall, F.;
- Eyre, D.W.;
- Ardeshna, K.;
- Collins, G.P.
Publication type:
Article
RESULTS OF a PHASE II STUDY OF BRENTUXIMAB VEDOTIN IN THE FIRST LINE TREATMENT OF HODGKIN LYMPHOMA PATIENTS CONSIDERED UNSUITABLE FOR STANDARD CHEMOTHERAPY (BREVITY).
Published in:
Hematological Oncology, 2017, v. 35, p. 80, doi. 10.1002/hon.2437_68
By:
- Gibb, A.;
- Pirrie, S.;
- Linton, K.;
- Paterson, K.;
- Davies, A.;
- Collins, G.;
- Menne, T.;
- McKay, P.;
- Fields, P.;
- Miall, F.;
- Nagy, E.;
- Wheatley, K.;
- Warbey, V.;
- Barrington, S.;
- Radford, J.
Publication type:
Article

Found: 10